Related Experiment Video

Updated: Aug 14, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Lipid-lowering therapy for elderly patients at risk for coronary events and stroke

Kevin A Courville1, Carl J Lavie, Richard V Milani

  • 1Department of Cardiovascular Diseases, Ochsner Clinic Foundation, 1514 Jefferson Highway, New Orleans, LA 70121, USA.

The American Heart Hospital Journal
|December 7, 2005
PubMed

Insights

Hyperlipidemia management in the elderly, especially with statins, significantly reduces cardiovascular diseases like coronary heart disease and stroke. This therapy is safe and beneficial for older adults, aiding in disease prevention.

Area of Science:

  • Gerontology
  • Cardiology
  • Pharmacology

Background:

  • Hyperlipidemia is a key risk factor for cardiovascular diseases (CVD), particularly coronary heart disease (CHD), in elderly individuals.
  • While not a primary stroke risk factor, hyperlipidemia treatment benefits extend to stroke reduction in this demographic.

Purpose of the Study:

  • To review the efficacy and safety of lipid-lowering therapies, primarily statins, for cardiovascular disease prevention in the elderly.
  • To assess the impact of statin therapy on stroke and dementia in older populations.

Main Methods:

  • Review of existing clinical data and studies on hyperlipidemia treatments in elderly patients.
  • Analysis of safety profiles and cardiovascular event reduction associated with statins, fibrates, and niacin.

Main Results:

  • Statin therapy, alone or combined with other treatments, effectively reduces coronary heart disease events and stroke in the elderly.
  • Statin therapy demonstrates a neutral or slightly beneficial effect on dementia and is generally safe for most elderly patients.

Conclusions:

  • Aggressive lipid management, particularly with statins, is crucial for primary and secondary CVD prevention in the elderly.
  • Lipid-lowering therapies are well-tolerated and effective in reducing major cardiovascular events in older adults.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...